HIGHLIGHTS
- who: Valentin Jacquier from the IRCM, Institut de Recherche en Cancu00e9rologie de Montpellier, INSERM, University of Montpellier, ICM, Montpellier, France have published the research: RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53, in the Journal: (JOURNAL)
- how: Using a luciferase reporter assay the authors showed that increasing doses of p53 inhibited the luciferase activity driven by the GLUT3 promoter (Fig 5a) and that RIP140 reinforced this inhibition (Fig 5b).
- future: Whether there is a ternary complex or if the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.